UK markets closed

Merus N.V. (MRUS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
25.64-0.27 (-1.04%)
As of 11:36AM EST. Market open.
Sign in to post a message.
  • a
    anglesm
    Down day tomorrow -

    Merus N.V. Announces Proposed Public Offering of Common Shares
    November 4, 2021 at 4:07 PM EDT

    UTRECHT, The Netherlands and CAMBRIDGE, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of its common shares (the “Offer Shares”). All of the common shares are being offered by Merus. In addition, Merus expects to grant the underwriters a 30-day option to purchase an additional 15% of the Offer Shares (the “Option Shares” and together with the Offer Shares, the “Shares”). The offering is subject to market conditions and other closing conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

    Merus intends to use the net proceeds from the offering to advance the clinical development of its product candidates, for preclinical research and technology development, and for working capital and general corporate purposes.

    Jefferies LLC and SVB Leerink LLC are acting as joint book-running managers for the offering. Kempen & Co is acting as lead manager for the offering. H.C. Wainwright & Co. and Roth Capital Partners are acting as co-managers for the offering.

    The offering will be made pursuant to a shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission (“SEC”) on May 7, 2021 and was effective upon filing....
  • a
    anglesm
    Merus Announces Pricing of Public Offering of Common Shares
    November 4, 2021 at 9:01 PM EDT

    UTRECHT, The Netherlands, and CAMBRIDGE, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics™), today announced the pricing of an underwritten public offering of 3,859,650 common shares, at a public offering price of $28.50 per share (the “Offer Shares”). Merus also granted the underwriters a 30-day option to purchase up to an additional 578,947 common shares (the “Option Shares” and together with the Offer Shares, the “Shares”). The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses and excluding the underwriters’ option to purchase the Option Shares, are approximately $110.0 million. All of the shares in the offering are to be sold by Merus.

    The offering is expected to close on or about November 9, 2021, subject to customary closing conditions.

    Merus intends to use the net proceeds from the offering to advance the clinical development of its product candidates, for preclinical research and technology development, and for working capital and general corporate purposes.
  • p
    peter
    Well, all I can say is it is very rare to see this kind of rate of tumor shrinkage in heavily pretreated patients in P1s for non chemotherapies in solid tumors, with very low toxicity.
    Quite impressive really. The shorts are talking about time to approval being 3 years. Not with these rates of response. This will get approved based on ORR out of registrational P2, if the data hold up and the DOR is decent.
  • S
    S
    Market CORRECTION starts any days, do not hold your long positions.🔊🔊
    with a over 30% stock market crash coming next 4 to 5 because infrastructure bill
    and$ 3.5trillion bill wont get sign in 2021 will cause a USA economic recovery delayed and stalled for 15 months and no jobs created ,stock market reaction will be very very scary scary over30pluspercentcrash to the stock market
  • B
    Bechody
    “S” must be in great pain as the more he shorts, they higher this climbs and the longer he hold, the more he losses.
  • B
    Bechody
    30+ by close or AH. Buy with confidence.
  • R
    Ryan
    just like all stocks with huge runups, they have to pull back to consolodate or they will crash. I think this will drop $26 in the AH and without any momentum will break 25 in the AM. This could crash much harder without more support.
  • B
    Bechody
    Poor bustards, are you still holding? $40’s are closer than 20’s. Get in now.
  • S
    S
    News release from Phase-1 clinical result are always 100% positive for any biotech companies
    but once they go into P-2 and P3 studies then the 80% of them are bound to fail. 🤐🤐👎
  • K
    Kari
    as operating at 80M loss per year and have about 200M cash on hand, does not seem like offering is a threat? Thoughts?
  • B
    Big D
    Is it true insiders are dumping shares?
  • B
    Bechody
    Buying more with my eyes closed.
  • L
    Livermore
    (PYPD) $7.30 -BIG Blockbuster Phase 3 Data coming during THIS quarter / Cathie Wood´s ARK Investment increases stake from 20k to over 600k shares in last months = 500%+ upsideee
    https://www.polypid.com/wp-content/uploads/2015/05/Capture-Pipeline-June-2021-1.png

    ++#+
  • S
    S
    Yesterday's huge gain will be evaporated and tank back to $10~$15 once massive
    market correction starts any day now.
  • S
    S
    It will take another 3-years to complete the Phase3 ( and there's no guaranty FDA approval !)
    👎👎News release on Phase-1 clinical result are always 100% positive for any biotech companies
    but once they go into P-2 and P3 studies then the 80% of them are bound to fail. 🤐🤐
  • B
    Bechody
    This is very healthy. Buy the dip. Don’t believe the “Dilution” B$. It’s all fake news desperate shorts are making up.
  • B
    Bechody
    I told you to buy. You didn’t listen. Don’t be blue. It’s not too late. Get in for 40’s.
  • B
    Bechody
    Ryan, are you still awaiting a pull back ?
  • S
    S
    Today's huge run up is NOT even Phase-1 !!!👎👎👎
    Take your profit and RUN !! A 30% stock market crash coming
    any day and don't hold you long positions.